Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Advanced Enzyme Technologies Ltd

NSE: ADVENZYMES · BSE: 540025 · Pharmaceuticals & Biotechnology · 62 announcements

Share price
₹270.05
Market cap
₹3,024 Cr
Revenue (annual)
₹745.8 Cr
Net profit (annual)
₹168.7 Cr
P/E (TTM)
18.2×Sector 47.3×
Promoter holding
43.24%-0.02% QoQ
FII holding
26.70%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:12 IST BSE
Board Meeting Date

Advanced Enzyme Technologies Board Meeting Date

Advanced Enzyme Technologies Ltd has scheduled a board meeting on May 09, 2026, to approve FY2026 annual financial statements and recommend dividends. The company also announced that its trading window will remain closed until May 11, 2026.

17:27 IST NSE
Management Change

Advanced Enzyme Technologies Management Change

Mr. Dipak Roda has resigned as Senior Vice President - Marketing and Business Development at Advanced Enzyme Technologies Limited, effective April 09, 2026. He is leaving to pursue new opportunities outside the company. He also resigned as Non-Executive Director of the subsidiary, Advanced Enzytech Solutions Limited.